摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-methoxy-3-(6'-methoxy-1',2',3',4',-tetrahydronaphth-1'-yl)-1,2-dihydronaphthalene | 16821-33-3

中文名称
——
中文别名
——
英文名称
7-methoxy-3-(6'-methoxy-1',2',3',4',-tetrahydronaphth-1'-yl)-1,2-dihydronaphthalene
英文别名
7-methoxy-3-(6-methoxy-1,2,3,4-tetrahydronaphthyl)-1,2-dihydronaphthalene;6,6'-Dimethoxy-1,2,3,4,3',4'-hexahydro-[1,2']binaphthyl;6,6'-Dimethoxy-1,2,3,3',4,4'-hexahydro-1,2'-binaphthyl;7-methoxy-3-(6-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)-1,2-dihydronaphthalene
7-methoxy-3-(6'-methoxy-1',2',3',4',-tetrahydronaphth-1'-yl)-1,2-dihydronaphthalene化学式
CAS
16821-33-3
化学式
C22H24O2
mdl
——
分子量
320.431
InChiKey
LQIYWRYUYNEUAP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    76-77 °C
  • 沸点:
    233-238 °C(Press: 3 Torr)
  • 密度:
    1.122±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    5.3
  • 重原子数:
    24
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    18.5
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    The Dimerization of 6-Methoxy-3,4-dihydronaphthalene
    摘要:
    DOI:
    10.1021/ja01233a003
  • 作为产物:
    参考文献:
    名称:
    A Glucomannan and Chitosan Fiber Supplement Decreases Plasma Cholesterol and Increases Cholesterol Excretion in Overweight Normocholesterolemic Humans
    摘要:
    Objective: Both chitosan and glucomannan have demonstrated hypocholesterolemic effects. A recent study in rats indicates that the combination of the two is also a potent hypocholesterolemic agent that increases fecal fat excretion. The objective of the present study was to determine the hypocholesterolemic effect of a supplement containing equal amounts of chitosan and glucomannan on blood lipid concentrations and fecal excretion of fat, neutral sterols and bile acids.Methods: Twenty-one overweight normocholesterolemic subjects (I I males and 10 females) were fed 2.4 g/day of a supplement containing equal amounts of chitosan and glucomannan. Prior to taking the supplement (initial period) and after 28 days (final period), blood was drawn for measurement of serum lipids and a three-day fecal sample collected for determination of fat, neutral sterol and bile acid excretion. Subjects maintained their normal dietary and activity patterns during the study.Results: Caloric intake and intake of fat and dietary fiber (excluding the supplement) did not differ between the initial and final periods. Serum total, HDL and LDL cholesterol concentrations were significantly lower (P < 0.05) in the final period compared to the initial period. Serum triacylglycerol concentration did not change between periods. There was a trend towards greater fecal excretion of neutral sterols and bile acids (p = 0.13 and 0.16, respectively) in the final period. However. fecal fat excretion did not differ between periods.Conclusions: Serum cholesterol reduction by a chitosan/glucomannan supplement is likely mediated by increased fecal steroid excretion and is not linked to fat excretion.
    DOI:
    10.1080/07315724.2002.10719246
点击查看最新优质反应信息

文献信息

  • Synthesis of 5-Alkylidene-6-(dimethylamino)methyl-1,3-cyclohexadienes from α-Substituted Benzyldimethylammoniomethylides
    作者:Yoshio Machida、Naohiro Shirai、Yoshiro Sato
    DOI:10.1055/s-1991-26393
    日期:——
    2-Substituted 5-alkylidene-6-(dimethylamino)methyl-1,3-cyclohexadienes (E)-4 and (Z)-4 were prepared by the reaction of α,4-disubstituted dimethyl[(trimethylsilyl)methyl]benzylammonium iodides 2 with cesium fluoride. Their E-isomers were stable at room temperature and could be used in the Diels-Alder reaction. Some related reactions are also described.
    通过铯氟化物与α,4-二取代的二甲基[(三甲基硅基)甲基]苄基铵碘化物的反应,制备了2-取代的5-烷叉基-6-(二甲基氨基)甲基-1,3-环己二烯(E)-4和(Z)-4。其E-异构体在室温下稳定,并可用于Diels-Alder反应。同时,还描述了一些相关的反应。
  • Acid Catalysed Reaction of Indanones, Tetralones and Benzosuberone with Neopentyl Glycol and other Alkanediols under Forced Conditions
    作者:Masao Imai、Goreti Ribeiro Morais、Bassam al-Hindawi、Mazen A. M. al-Sulaibi、Mohammad Meetani、Thies Thiemann
    DOI:10.3184/030823410x12753214605445
    日期:2010.6
    Upon reaction with an excess of 2,2-dimethylpropane-1,3-diol (neopentyl glycol, NPG) under acid catalysis, indanones and tetralones yield indenes and dihydronaphthalenes, respectively. The reaction can also be carried out with butane-1,3-diol.
    在酸催化下与过量的 2,2-二甲基丙烷-1,3-二醇(新戊二醇,NPG)反应后,茚酮和四氢萘酮分别生成茚和二氢萘。该反应也可以用丁烷-1,3-二醇进行。
  • STRUCTURAL MODELS OF CORTIN COMPOUNDS IN THE NAPHTHALENE SERIES
    作者:LOUIS LONG、ALFRED BURGER
    DOI:10.1021/jo01206a010
    日期:1941.11
  • Controlling benzylic functionality and stereochemistry: 2. Synthesis of the pseudopterosin aglycone
    作者:Stuart W. McCombie、Brian Cox、Ashit K. Ganduly
    DOI:10.1016/s0040-4039(00)71243-3
    日期:1991.5
    Homologation, cyclisation, and reduction converted the tetralin (2) to the hexahydrophenalenol (8), which was methylated to afford (19) via alkoxide-directed metalation. The degree of stereoselectivity resulting from reactions of (19) and congeners with allylsilane - Lewis acid combinations was markedly dependent upon substitution patterns, whereas Et2AlCN-SnCl4 produced pseudoaxial nitriles. The trimethyl nitrile (24) was elaborated to the pseudopterosin aglycone (4).
  • A Glucomannan and Chitosan Fiber Supplement Decreases Plasma Cholesterol and Increases Cholesterol Excretion in Overweight Normocholesterolemic Humans
    作者:Daniel D. Gallaher、Cynthia M. Gallaher、Gregory J. Mahrt、Timothy P. Carr、Carolyn H. Hollingshead、Robert Hesslink、John Wise
    DOI:10.1080/07315724.2002.10719246
    日期:2002.10
    Objective: Both chitosan and glucomannan have demonstrated hypocholesterolemic effects. A recent study in rats indicates that the combination of the two is also a potent hypocholesterolemic agent that increases fecal fat excretion. The objective of the present study was to determine the hypocholesterolemic effect of a supplement containing equal amounts of chitosan and glucomannan on blood lipid concentrations and fecal excretion of fat, neutral sterols and bile acids.Methods: Twenty-one overweight normocholesterolemic subjects (I I males and 10 females) were fed 2.4 g/day of a supplement containing equal amounts of chitosan and glucomannan. Prior to taking the supplement (initial period) and after 28 days (final period), blood was drawn for measurement of serum lipids and a three-day fecal sample collected for determination of fat, neutral sterol and bile acid excretion. Subjects maintained their normal dietary and activity patterns during the study.Results: Caloric intake and intake of fat and dietary fiber (excluding the supplement) did not differ between the initial and final periods. Serum total, HDL and LDL cholesterol concentrations were significantly lower (P < 0.05) in the final period compared to the initial period. Serum triacylglycerol concentration did not change between periods. There was a trend towards greater fecal excretion of neutral sterols and bile acids (p = 0.13 and 0.16, respectively) in the final period. However. fecal fat excretion did not differ between periods.Conclusions: Serum cholesterol reduction by a chitosan/glucomannan supplement is likely mediated by increased fecal steroid excretion and is not linked to fat excretion.
查看更多

同类化合物

(S)-(+)-5,5'',6,6'',7,7'',8,8''-八氢-3,3''-二叔丁基-1,1''-二-2-萘酚,双钾盐 顺式-4-(4-氯苯基)-1,2,3,4-四氢-N-甲基-1-萘胺盐酸盐 顺式-4-(3,4-二氯苯基)-1,2,3,4-四氢N-叔丁氧羰基-1-萘胺 顺式-1-苯甲酰氧基-2-二甲基氨基-1,2,3,4-四氢萘 顺式-1,2,3,4-四氢-5-环氧丙氧基-2,3-萘二醇 顺式-(1S,4S)-N-甲基-4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺扁桃酸盐 顺-5,6,7,8-四氢-6,7-二羟基-1-萘酚 顺-(+)-5-甲氧基-1-甲基-2-(二正丙基氨基)萘满马来酸 阿洛米酮 阿戈美拉汀杂质醇(A) 阿戈美拉汀杂质 钠2-羟基-7-甲氧基-1,2,3,4-四氢-2-萘磺酸酯 金钟醇 邻烯丙基苯基溴化镁 那高利特盐酸盐 那高利特 过氧化,1,1-二甲基乙基1,2,3,4-四氢-1-萘基 贝多拉君 螺<4.7>十二烷 蔡醇酮 萘磺酸,二癸基-1,2,3,4-四氢- 萘并[2,3-d]咪唑,2-乙基-5,6,7,8-四氢-(6CI) 萘亚胺 苯甲酸-(5,6,7,8-四氢-[2]萘基酯) 苯甲丁氮酮 苯甲丁氮酮 苯甲丁氮酮 苯并烯氟菌唑 舍曲林二甲基杂质盐酸盐 舍曲林EP杂质B 舍曲林 羟甲基四氢萘酚 美曲唑啉 罗替戈汀硫酸盐 罗替戈汀杂质18 罗替戈汀中间体 罗替戈汀中间体 罗替戈汀 罗替戈汀 纳多洛尔杂质 米贝地尔(二盐酸盐) 盐酸舍曲林 盐酸舍曲林 盐酸罗替戈汀 盐酸左布诺洛尔 盐酸四氢唑林 甲基缩合物 甲基6-[1-(3,5,5,8,8-五甲基-5,6,7,8-四氢-2-萘基)环丙基]烟酸酯 甲基-(2-吡咯烷-1-基甲基-1,2,3,4-四氢-萘-2-基)-胺 环丙烯并[a]茚,1-溴-1-氟-1,1a,6,6a-四氢-